Validation of occupancy images from pet data. A novel endpoint for drug discovery

Active Project Grant Awarded Last action

Award ID
R01EB032658
Recipient
Awarding agency
Obligated
$7,109,365

Award facts

Completion date 95% complete
Originally
Place of performance
Connecticut, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
The most useful application of pet imaging in CNS drug development is to measure occupancy of new drug candidates at target binding sites (e.g., receptors, transporters, and enzymes). These target occupancy (to) studies -often starting in primates and progressing to phase 1 in humans - are very helpful for in vivo dose- finding, deciding whether to advance a candidate compound to more costly later phase trials, and optimizing the design of later phase studies. Current state of the art: a common and informative approach to analysis of to data is the "lassen plot". The lassen plot yields two point estimates: a fractional occupancy of the target by the drug (ODRUG) and the nondisplaceable uptake of the tracer (VND). Assumptions underlying this popular method are that (a) both measures are uniform across the whole brain and (B) the pet tracer binds to the identical population of target sites as the candidate drug. Technology GAP: there are important cases in which one or more assumption of the lassen plot is violated. In such cases, (1) the outcome of the to study may be biased, (2) manual intervention may be required, (3) proper interpretation will depend on prior knowledge of the spatial distribution of target subtypes, and in any case, (4) the standard method offers little to no information on regional variation in ODRUG. Basic development in the lab: in our research group at yale, we have developed an extension of the standard lassen plot that provides information about local variation in ODRUG and VND. The outcomes of our new "lassen plot filter" (LPF) algorithm are voxel-by-voxel estimates of ODRUG, VND and EC50 (i.e., `occupancy images', `nondisplaceable uptake, and drug affinity, images'). We believe these novel images represent much more informative outcomes of to studies than standard measures for identifying precise locations of maximal specific action of drugs. For example, when assumptions are violated, occupancy images will be less biased than point estimates. The new images could serve as richer endpoints to drive go/no-go decisions on candidate compounds based on drug action at specific brain locations of greatest therapeutic interest. Academic-industrial partnership. Our industrial partner, a company with extensive experience in conducting to studies, will provide US with very valuable archival data in humans and nonhuman primates for testing and validating our LPF algorithm. In the present project, we will (1) analyze simulated data with known occupancy distributions. (2) RE-analyze archival data that represent different cases and/or violations of standard assumptions. (3) perform circumscribed studies in primates to confirm the biological interpretations of our new images. The work will be complete when we have fully characterized and optimized the performance of our LPF algorithm. In the long term, our goal is for a validated version of our voxel-by-voxel analysis of to studies, to be adopted widely, to the benefit of end-users, to speed drug development.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $58,119
Amendment $58,119
Amendment $523,088
Amendment $523,088
Amendment $523,088
Amendment $59,923
Amendment $59,923
Amendment $539,327
Amendment $539,327
Amendment $539,327
Amendment $597,847
Amendment $597,847
Amendment $597,847
Amendment $597,847
Amendment $0
Amendment $0
Amendment $0
Amendment $647,324
Original award $647,324
Show all 21

Subawards

Subrecipient Amount Awarded
Invicro LLC Objectives: to validate a new image?processing algorithm, the lassen plot filter, for use with pet data from target?occupancy studies. Tasks/deliverables: (1)… $20,000
Invicro LLC Objectives: To validate a new image?processing algorithm, The Lassen Plot Filter, for use with PET data from target?occupancy studies. Tasks/Deliverables: (1)… $96,394
Invicro LLC Objectives: To validate a new image processing algorithm, The Lassen Plot Filter, for use with PET data from target occupancy studies. Tasks/Deliverables: (1)… $236,826

Quick answers

Who received award R01EB032658?

R01EB032658 was awarded to Yale Univ by National Institute of Biomedical Imaging and Bioenginering (National Institutes of Health) on May 1, 2022.

How much is award R01EB032658 worth?

$7,109,365 has been obligated on R01EB032658.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login